
ThinkCyte
Developer of an image-based cell sorting technology designed to advance single-cell analysis for research, diagnostics, and therapeutics. The company's ghost cytometry technology integrates advanced o...
Valuation
$106.4M
Latest known
Share Price
N/A
Total Raised
$84.7M
Last Round
N/A